Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia
Public ClinicalTrials.gov record NCT04103450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the long-term safety of vibegron when dosed up to 52 weeks in men with overactive bladder (OAB) symptoms on pharmacological therapy for Benign Prostatic Hyperplasia (BPH) who previously completed treatment in Study URO-901-3005 (NCT03902080).
Study identification
- NCT ID
- NCT04103450
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 276 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 18, 2019
- Primary completion
- Jul 28, 2022
- Completion
- Jul 28, 2022
- Last update posted
- Aug 20, 2024
2019 – 2022
United States locations
- U.S. sites
- 31
- U.S. states
- 16
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Private Practice | Huntsville | Alabama | 35801 | — |
| Clinical Trials Research | Lincoln | California | 95648 | — |
| American Institute of Research | Los Angeles | California | 90017 | — |
| Tri Valley Urology Medical Group | Murrieta | California | 92562 | — |
| Northern California Research Corp | Sacramento | California | 95821 | — |
| San Diego Clinical Trials | San Diego | California | 91942 | — |
| Skyline Urology | Torrance | California | 90505 | — |
| Imagine Research of Palm Beach County - Urology | Boynton Beach | Florida | 33435 | — |
| Tampa Bay Medical Research | Clearwater | Florida | 33761 | — |
| Quantum Clinical Trials | Miami | Florida | 33140 | — |
| Urology Center Of Florida | Pompano Beach | Florida | 33060 | — |
| Precision Clinical Research | Sunrise | Florida | 33351 | — |
| Clinical Research of Central Florida | Winter Haven | Florida | 33880 | — |
| DelRicht Research | New Orleans | Louisiana | 70115 | — |
| Regional Urology, LLC | Shreveport | Louisiana | 71106 | — |
| Boston Clinical Trials Inc - Urology | Boston | Massachusetts | 02131 | — |
| Bay State Clinical Trials, Inc. | Watertown | Massachusetts | 02472 | — |
| Beaumont Hospital Royal Oak - Urology Research | Royal Oak | Michigan | 48703 | — |
| CentraCare Clinic - Adult & Pediatric Urology | Sartell | Minnesota | 56377 | — |
| Poplar Bluff Urology | Poplar Bluff | Missouri | 63901 | — |
| Adult & Pediatric Urology P.C. - Urology | Omaha | Nebraska | 68114 | — |
| Excel Clinical Research - Internal Medicine | Las Vegas | Nevada | 89109 | — |
| Private Practice | Las Vegas | Nevada | 89144 | — |
| Premier Urology Group, LLC | Edison | New Jersey | 08837 | — |
| New Jersey Urology NJU | Englewood | New Jersey | 07631 | — |
| AccuMed Research Associates | Garden City | New York | 11530 | — |
| Urological Surgeons of Long Island | Garden City | New York | 11530 | — |
| Clinical Research Solutions | Middleburg Heights | Ohio | 44130 | — |
| Advances In Health, Inc. | Houston | Texas | 77030 | — |
| Wasatch Clinical Research LLC | Salt Lake City | Utah | 84107 | — |
| Seattle Urology Research Center | Burien | Washington | 98166 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04103450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2024 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04103450 live on ClinicalTrials.gov.